XML 16 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Condensed Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Dec. 30, 2018
Dec. 31, 2017
Cash flows from operating activities    
Net earnings (loss) $ 142,081 $ 65,694
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation and amortization 42,511 40,320
Write-off of assets relating to exit activities 4,498 210
Derivatives not designated in hedging relationships:    
Net losses (gains) 390 (105)
Cash settlements (865) (234)
Provision for doubtful accounts 849 775
Deferred income taxes (222) (7,228)
Non-cash interest expense 953 1,289
Stock-based compensation 14,587 14,773
(Gain) loss on disposal of property, plant, and equipment (157) 69
Changes in assets and liabilities, net of effects of acquisitions:    
Accounts receivable 21,860 12,987
Inventories (36,440) (44,389)
Prepaid and other current assets (12,507) (1,241)
Other assets (1,260) (1,142)
Accounts payable (649) (10,619)
Accrued expenses 14,306 (30,485)
Other liabilities (23,511) 89,228
Net cash provided by operating activities 166,424 129,902
Cash flows from investing activities    
Capital expenditures (52,672) (43,086)
Purchase of businesses (650,000) (2,964)
Proceeds from disposal of property, plant, and equipment 549 395
Net cash used in investing activities (702,123) (45,655)
Cash flows from financing activities    
Net repayments on short-term debt (13,564) (1,376)
Proceeds from Amended 2017 Term Loan 299,105 150,000
Repayments of 2011 Term Loan 0 (127,500)
Debt issuance costs (1,235) (2,677)
Option proceeds 9,044 758
Payment of taxes related to net share settlement of equity awards (3,384) (7,477)
Purchase of treasury stock (25,000) (121,191)
Dividends paid to stockholders (22,280) (22,339)
Other 29 (19)
Net cash provided by (used in) financing activities 451,215 (51,521)
Effect of exchange rate changes on cash and cash equivalents (40,476) 38,267
Net (decrease) increase in cash and cash equivalents (124,960) 70,993
Cash and cash equivalents at beginning of period 522,118 500,329
Cash and cash equivalents at end of period 397,158 571,322
Non-cash investing and financing activities:    
Common stock issued as partial consideration for Alpha acquisition 100,000 0
Amended Credit Facility, due 2022    
Cash flows from financing activities    
Proceeds from Revolver borrowings 454,500 356,750
Repayments of Revolver borrowings (246,000) (111,450)
2011 Credit Facility, due 2018    
Cash flows from financing activities    
Proceeds from Revolver borrowings 0 147,050
Repayments of Revolver borrowings $ 0 $ (312,050)